Danaher Corporation (DHR) Income Statement Analysis

See more : Vedant Fashions Limited (MANYAVAR.BO) Income Statement Analysis – Financial Results

Complete financial analysis of Danaher Corporation (DHR) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Danaher Corporation, a leading company in the Medical – Diagnostics & Research industry within the Healthcare sector.

You may be interested

Danaher Corporation (DHR)

Industry: Medical - Diagnostics & Research

Sector: Healthcare

Website: https://www.danaher.com

About Danaher Corporation

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.

Metric	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999	1998	1997	1996	1995	1994	1993	1992	1991	1990	1989	1988	1987	1986	1985
Revenue	23.89B	31.47B	29.45B	22.28B	17.91B	19.89B	18.33B	16.88B	20.56B	19.91B	19.12B	18.26B	16.09B	13.20B	11.18B	12.70B	11.03B	9.60B	7.98B	6.89B	5.29B	4.58B	3.78B	3.78B	3.20B	2.91B	2.05B	1.81B	1.49B	1.29B	1.07B	949.00M	831.60M	840.00M	749.10M	714.60M	615.00M	446.00M	298.00M
Cost of Revenue	9.86B	12.52B	11.50B	9.81B	7.93B	8.79B	8.14B	7.55B	9.80B	9.47B	9.16B	8.85B	7.91B	6.58B	5.90B	6.76B	5.99B	5.35B	4.54B	4.00B	3.15B	2.79B	2.34B	2.17B	1.83B	1.71B	1.31B	1.17B	981.10M	889.70M	753.00M	670.30M	601.90M	573.30M	499.10M	462.00M	406.40M	342.40M	239.70M
Gross Profit	14.03B	18.95B	17.95B	12.48B	9.98B	11.11B	10.19B	9.33B	10.76B	10.44B	9.96B	9.41B	8.18B	6.63B	5.28B	5.94B	5.04B	4.24B	3.45B	2.89B	2.14B	1.79B	1.44B	1.61B	1.36B	1.20B	744.60M	640.70M	505.70M	399.00M	314.10M	278.70M	229.70M	266.70M	250.00M	252.60M	208.60M	103.60M	58.30M
Gross Profit Ratio	58.74%	60.21%	60.95%	55.98%	55.74%	55.83%	55.61%	55.29%	52.34%	52.44%	52.08%	51.56%	50.82%	50.19%	47.21%	46.78%	45.72%	44.22%	43.15%	41.99%	40.41%	39.02%	38.19%	42.66%	42.62%	41.15%	36.30%	35.36%	34.01%	30.96%	29.43%	29.37%	27.62%	31.75%	33.37%	35.35%	33.92%	23.23%	19.56%
Research & Development	1.50B	1.75B	1.74B	1.35B	1.13B	1.23B	1.13B	975.10M	1.24B	1.31B	1.25B	1.14B	1.02B	809.48M	632.65M	725.44M	601.42M	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
General & Administrative	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Selling & Marketing	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
SG&A	7.25B	8.52B	8.20B	6.90B	5.59B	6.47B	6.04B	5.61B	6.05B	5.70B	5.43B	5.18B	4.61B	3.67B	3.19B	3.35B	2.71B	2.74B	2.18B	1.80B	1.32B	1.09B	872.68M	909.90M	778.40M	722.10M	401.60M	345.90M	266.90M	208.50M	180.20M	180.60M	161.60M	165.50M	136.90M	130.40M	110.60M	61.30M	31.60M
Other Expenses	0.00	-226.00M	547.00M	39.00M	12.00M	37.20M	72.80M	223.40M	12.40M	156.50M	0.00	0.00	0.00	0.00	-85.12M	0.00	-14.34M	-16.38M	4.60M	-8.14M	-22.50M	2.78B	0.00	149.72M	126.40M	108.70M	76.10M	68.60M	58.50M	44.60M	40.90M	37.10M	33.20M	25.60M	19.10M	17.60M	13.50M	9.30M	6.80M
Operating Expenses	8.83B	10.26B	10.49B	8.24B	6.71B	7.70B	7.17B	6.58B	7.29B	7.01B	6.68B	6.32B	5.56B	4.48B	3.74B	4.07B	3.30B	2.73B	2.18B	1.79B	1.29B	1.09B	872.68M	1.06B	904.80M	830.80M	477.70M	414.50M	325.40M	253.10M	221.10M	217.70M	194.80M	191.10M	156.00M	148.00M	124.10M	70.60M	38.40M
Cost & Expenses	18.69B	22.78B	21.99B	18.05B	14.64B	16.49B	15.31B	14.13B	17.09B	16.48B	15.84B	15.17B	13.47B	11.06B	9.64B	10.83B	9.29B	8.08B	6.72B	5.78B	4.45B	3.88B	3.21B	3.23B	2.74B	2.54B	1.78B	1.59B	1.31B	1.14B	974.10M	888.00M	796.70M	764.40M	655.10M	610.00M	530.50M	413.00M	278.10M
Interest Income	303.00M	41.00M	11.00M	71.00M	139.00M	9.20M	7.50M	200.00K	5.30M	16.70M	5.70M	3.20M	5.15M	6.07M	5.03M	10.00M	6.09M	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Interest Expense	286.00M	211.00M	238.00M	275.00M	108.60M	157.40M	162.70M	184.40M	162.80M	122.70M	145.90M	157.50M	141.64M	120.78M	122.66M	130.17M	109.70M	0.00	0.00	0.00	0.00	43.65M	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation & Amortization	2.17B	2.13B	2.17B	1.78B	1.19B	1.18B	1.24B	1.13B	1.05B	938.50M	895.00M	839.80M	634.93M	397.08M	341.59M	339.29M	268.49M	217.19M	176.97M	156.13M	133.44M	129.57M	178.39M	149.72M	126.40M	108.70M	76.10M	68.60M	58.50M	44.60M	40.90M	37.10M	33.20M	25.60M	19.10M	17.60M	13.50M	9.30M	6.80M
EBITDA	7.50B	9.71B	10.01B	6.59B	4.60B	4.28B	4.34B	4.03B	3.21B	4.54B	4.61B	4.01B	3.22B	2.86B	1.89B	2.22B	2.02B	1.74B	1.46B	1.26B	979.43M	824.41M	750.13M	701.87M	584.40M	498.70M	343.00M	294.80M	238.80M	190.50M	133.90M	98.10M	68.10M	101.20M	113.10M	122.20M	98.00M	42.30M	26.70M
EBITDA Ratio	31.39%	34.08%	34.29%	27.45%	25.74%	23.92%	23.68%	24.30%	22.07%	22.81%	21.84%	21.95%	20.24%	21.67%	16.89%	17.47%	18.09%	17.91%	18.11%	18.19%	18.08%	17.87%	21.68%	18.58%	18.65%	17.74%	16.72%	16.27%	16.06%	14.78%	11.76%	9.65%	7.49%	11.42%	14.12%	16.95%	15.63%	7.69%	6.68%
Operating Income	5.20B	8.69B	7.47B	4.23B	3.27B	3.40B	3.02B	2.75B	3.47B	3.43B	3.27B	3.17B	2.62B	2.17B	1.54B	1.87B	1.74B	1.52B	1.26B	1.11B	846.00M	701.12M	502.01M	552.15M	458.00M	366.80M	266.90M	226.20M	180.30M	145.90M	93.00M	61.00M	34.90M	75.60M	94.00M	104.60M	84.50M	33.00M	19.90M
Operating Income Ratio	21.77%	27.61%	25.35%	18.99%	18.25%	17.11%	16.48%	16.29%	16.87%	17.23%	17.13%	17.33%	16.27%	16.41%	13.79%	14.72%	15.79%	15.82%	15.84%	16.04%	15.98%	15.32%	13.27%	14.62%	14.33%	12.60%	13.01%	12.48%	12.13%	11.32%	8.72%	6.43%	4.20%	9.00%	12.55%	14.64%	13.74%	7.40%	6.68%
Total Other Income/Expenses	-158.00M	-390.00M	133.00M	264.00M	35.90M	237.80M	-82.40M	-123.90M	-122.80M	50.50M	291.10M	-154.30M	-289.95M	176.33M	-117.62M	-120.17M	-103.61M	-89.15M	-13.13M	-47.42M	-48.96M	-43.65M	-25.75M	-29.23M	-28.50M	-49.80M	-12.90M	-16.80M	-7.20M	-9.30M	-2.00M	-4.30M	-8.60M	-13.50M	-14.90M	-31.60M	-41.10M	-15.20M	-5.80M
Income Before Tax	5.04B	8.29B	7.60B	4.50B	3.31B	3.29B	2.94B	2.61B	3.32B	3.48B	3.57B	3.01B	2.45B	2.34B	1.42B	1.75B	1.64B	1.45B	1.23B	1.06B	797.04M	657.47M	476.26M	522.92M	429.50M	301.10M	253.80M	209.80M	173.10M	136.60M	91.00M	56.70M	26.30M	62.10M	79.10M	73.00M	43.40M	17.80M	14.10M
Income Before Tax Ratio	21.11%	26.35%	25.80%	20.17%	18.45%	16.55%	16.03%	15.47%	16.16%	17.48%	18.65%	16.49%	15.21%	17.74%	12.74%	13.78%	14.85%	15.07%	15.46%	15.35%	15.06%	14.36%	12.59%	13.84%	13.43%	10.35%	12.37%	11.58%	11.64%	10.60%	8.53%	5.97%	3.16%	7.39%	10.56%	10.22%	7.06%	3.99%	4.73%
Income Tax Expense	823.00M	1.08B	1.25B	849.00M	873.00M	641.90M	469.00M	457.90M	725.30M	883.40M	871.00M	711.50M	512.56M	549.71M	273.15M	431.68M	423.10M	324.14M	336.64M	311.72M	260.20M	223.33M	178.60M	198.71M	167.90M	118.20M	99.00M	81.80M	67.30M	54.90M	37.30M	25.10M	13.00M	26.40M	32.00M	33.00M	22.90M	9.10M	8.50M
Net Income	4.76B	7.21B	6.43B	3.65B	3.01B	2.65B	2.49B	2.55B	3.36B	2.60B	2.70B	2.39B	2.17B	1.79B	1.15B	1.32B	1.37B	1.12B	897.80M	746.00M	536.83M	290.39M	297.67M	324.21M	261.60M	182.90M	154.80M	207.80M	108.40M	81.70M	17.70M	31.60M	13.30M	35.70M	61.10M	39.00M	20.10M	8.70M	5.60M
Net Income Ratio	19.94%	22.91%	21.84%	16.36%	16.80%	13.33%	13.60%	15.13%	16.33%	13.05%	14.10%	13.10%	13.50%	13.58%	10.30%	10.38%	12.42%	11.69%	11.24%	10.83%	10.14%	6.34%	7.87%	8.58%	8.18%	6.29%	7.55%	11.47%	7.29%	6.34%	1.66%	3.33%	1.60%	4.25%	8.16%	5.46%	3.27%	1.95%	1.88%
EPS	6.44	9.80	8.77	4.97	3.48	3.78	3.58	3.69	4.81	3.70	3.87	3.45	3.21	2.74	1.80	2.07	2.20	1.82	1.46	1.21	0.88	0.48	0.52	0.57	0.46	0.34	0.33	0.44	0.23	0.09	0.04	0.07	0.03	0.09	0.16	0.10	0.06	0.03	0.02
EPS Diluted	6.38	9.64	8.61	4.89	3.43	3.73	3.53	3.65	4.74	3.63	3.80	3.36	3.11	2.64	1.73	1.98	2.10	1.74	1.38	1.15	0.84	0.47	0.50	0.56	0.45	0.33	0.32	0.43	0.23	0.09	0.04	0.07	0.03	0.09	0.16	0.10	0.05	0.03	0.02
Weighted Avg Shares Out	736.50M	725.10M	714.60M	706.20M	715.00M	700.60M	695.80M	691.20M	698.10M	702.20M	696.00M	693.40M	676.20M	653.20M	641.53M	638.72M	622.45M	615.97M	617.81M	617.93M	613.58M	600.90M	574.52M	569.88M	567.33M	559.26M	571.52M	532.27M	471.30M	933.23M	442.50M	451.43M	443.33M	420.00M	376.00M	380.49M	365.45M	316.36M	320.00M
Weighted Avg Shares Out (Dil)	743.10M	737.10M	736.80M	718.70M	725.50M	710.20M	706.10M	699.80M	708.50M	716.10M	711.00M	713.10M	701.20M	683.30M	671.48M	671.73M	658.92M	650.50M	655.97M	655.40M	646.28M	633.93M	607.39M	582.00M	584.36M	575.95M	589.38M	544.65M	476.48M	933.23M	442.50M	451.43M	443.33M	420.00M	376.00M	390.00M	382.86M	348.00M	320.00M

The Ultimate 5: My Highest-Conviction Dividend Stocks

September 24, 2024seekingalpha.com

I explore the idea of managing a highly concentrated portfolio and share how I narrowed down my highest-conviction dividend investments to just five stocks. I emphasize the importance of choosing reliable companies, future-proof wealth compounders, even in a compact portfolio...

Danaher Schedules Third Quarter 2024 Earnings Conference Call

September 19, 2024prnewswire.com

WASHINGTON , Sept. 19, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the third quarter 2024 on Tuesday, October 22, 2024 beginning at 8:00 a.m.

The Big 3: ANET, MET, DHR

September 19, 2024youtube.com

Today's Big 3 looks at companies trading at or near their 52-week highs but show very different long-term charts. Dan Deming joins Diane King Hall and Ben Lichtenstein to break down the technical trends of Arista Networks (ANET), MetLife (MET),...

Beckman Coulter and Scopio Labs Add World's First Digital Bone Marrow Imaging and Analysis to Long-Term Partnership

September 17, 2024prnewswire.com

BREA, Calif. and TEL AVIV, Israel , Sept.

Danaher Announces Quarterly Dividend

September 10, 2024prnewswire.com

WASHINGTON , Sept. 10, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.27 per share of its common stock, payable on October 25, 2024 to holders of...

Here's Why It is Appropriate to Retain Danaher Stock For Now

September 10, 2024zacks.com

DHR benefits from solid momentum across its Diagnostics segment. However, increasing expenses remain a concern.

Danaher Confirms Third Quarter and Full Year 2024 Guidance

September 4, 2024prnewswire.com

WASHINGTON , Sept. 4, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) (the "Company") confirmed its previously issued guidance for the third quarter and full year 2024 ahead of a previously scheduled analyst event.

HTHIY or DHR: Which Is the Better Value Stock Right Now?

August 27, 2024zacks.com

Investors with an interest in Diversified Operations stocks have likely encountered both Hitachi Ltd. (HTHIY) and Danaher (DHR).

Danaher to Webcast Diagnostics Investor & Analyst Meeting in Washington, D.C.

August 26, 2024prnewswire.com

WASHINGTON , Aug. 26, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) will host a live video webcast of its Diagnostics Investor and Analyst Meeting in Washington, D.C. on September 5, 2024 beginning at approximately 10:00 a.m.

Danaher: Lofty Price, Bright Future

August 22, 2024seekingalpha.com

Danaher's high valuation and flat 2024 EPS growth might raise eyebrows, but its track record, strategic acquisitions, and long-term growth potential make it a solid buy for those who can. Despite trading at a premium, Danaher's strong history, efficient operations,...

1 2 3 4 5 6 7 8 9 10

Source: https://incomestatements.info
Category: Stock Reports

Danaher Corporation (DHR) Income Statement Analysis – Financial Results

Leave a Reply Cancel reply

Recent Posts

Categories